Clinical Trial Update: Trial on Treatment of Patients With Primary Hyperoxaluria Type I With Pyridoxal-phosphate [Phase 2]

View source ↗

Summary

A completed Phase 2 study evaluated pyridoxal-phosphate for treating patients with Primary Hyperoxaluria Type I.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperoxaluria Type

Drugs mentioned

• Pyridoxal-phosphate (Pyridoxal-5'-phosphate)

Snippet

Sponsor: University of Cologne | Conditions: Primary Hyperoxaluria Type I | Phase 2 | Status: COMPLETED